| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403057 Microcapsules, method of making and their use |
| 06/11/2002 | US6403056 Administering agent; applying ultrasonic frequency |
| 06/11/2002 | US6403055 Carboxylated polyamine compound |
| 06/11/2002 | US6402037 Two-photon upconverting dyes and applications |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/06/2002 | WO2002044132A1 A process for the preparation of iopamidol and the new intermediates therein |
| 06/06/2002 | WO2002043806A2 In vivo delivery methods and compositions |
| 06/06/2002 | WO2002043775A2 Paramagnetic metal ion-based macrocyclic contrast agents |
| 06/06/2002 | WO2002043767A1 Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 06/06/2002 | WO2001089576A3 Preparation hypericin bonded with poly-n-vinylamides |
| 06/06/2002 | WO2000065346A9 Diagnosis of human kidney diseases |
| 06/06/2002 | WO1999002120A8 Compositions and methods for reversibly increasing permeability of biomembranes |
| 06/06/2002 | US20020068860 Comprises glucose oxidase emulsion with perfluorocarbon which is used with miniature polarographic device; gels |
| 06/06/2002 | US20020068747 Inhibitors of prenyl-protein transferase |
| 06/06/2002 | US20020068092 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 06/06/2002 | US20020068089 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/06/2002 | US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/06/2002 | US20020068037 Cascade polymer bound complexing compounds, their complexes and conjugates, process for their production, and pharmaceutical agents containing them |
| 06/06/2002 | DE10040381C1 Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with sugar residues, processes for their preparation and their use |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/05/2002 | EP1210354A1 Prodrugs for liver specific drug delivery |
| 06/05/2002 | EP1210353A1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 06/05/2002 | EP1210126A2 Viscosity-standardised compositions which facilitate swallowing in dysphagic subjects |
| 06/05/2002 | EP1210125A2 L-selectin contrast agents |
| 06/05/2002 | EP1210124A2 Targeting multimeric imaging agents through multilocus binding |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210069A2 Large porous particles by spray-drying |
| 06/05/2002 | EP1210068A2 Use of simple amino acids to form porous particles |
| 06/05/2002 | EP0735900B1 Paramagnetic diagnostic formulations and their method of use |
| 06/05/2002 | EP0670832B1 Hepatobiliary magnetic resonance contrast agents |
| 06/05/2002 | CN1351889A Magnetic contrast medium composition and its preparing method |
| 06/04/2002 | US6399043 Radiolabeled macrocyclic gadolinium complexes with substantially better neural compatibility; enhanced signal intensity for nuclear spin tomography; water solubility and low osmolality; stable; nmr; radioimaging |
| 06/04/2002 | US6399042 4-fluoroalkyl-3-halophenyl nortropanes |
| 06/04/2002 | US6397849 Methods of ophthalmic administration |
| 05/30/2002 | WO2002042321A2 Mixed fibrils |
| 05/30/2002 | WO2002041870A2 Production and use of a targeted diagnostic system |
| 05/30/2002 | WO2002041760A2 Fluorescence-mediated molecular tomography |
| 05/30/2002 | WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 05/30/2002 | WO2001068679A3 Peptides targeting specifically tumor-derived endothelial cells |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | US20020066117 Transgenic animal and methods |
| 05/30/2002 | US20020065467 Methods and apparatus for monitoring and quantifying the movement of fluid |
| 05/30/2002 | US20020064829 Human tumor necrosis factor delta and epsilon |
| 05/30/2002 | US20020064502 Magnetic particles for diagnostic purposes |
| 05/30/2002 | CA2789080A1 Fluorescence-mediated molecular tomography |
| 05/30/2002 | CA2725716A1 Method of making 5, 10, 15, 20-tetrakis(carboxyphenyl) porphine solutions and compositions thereof |
| 05/30/2002 | CA2363951A1 Modulating ramp activity |
| 05/29/2002 | EP1209469A1 Production and use of a targeted diagnostic system |
| 05/29/2002 | EP1208855A1 Novel embolizing compositions |
| 05/29/2002 | EP1208200A2 Transgenic animal model for neurodegenerative diseases |
| 05/29/2002 | EP1207910A2 Improved container composition for diagnostic agents |
| 05/29/2002 | CN1351664A DNA sequence and recombination production of a graminae allergen |
| 05/29/2002 | CN1351505A Short-chain peptide dye conjagates used as contrast agents for optical diagnostics |
| 05/28/2002 | US6395744 Administering apomorphine and androgen |
| 05/28/2002 | US6395275 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 05/28/2002 | US6395257 Administering indocyanine dye of specific structure to individual for diagnostic imaging or antitumor therapy |
| 05/28/2002 | US6395254 Diagnosis of tumors and inflammatory disease |
| 05/28/2002 | US6394965 Tissue marking using biocompatible microparticles |
| 05/28/2002 | CA2250168C High volume hyperpolarizer for spin-polarized noble gas |
| 05/28/2002 | CA2183740C Magnetic resonance imaging using hyperpolarized noble gases |
| 05/28/2002 | CA2131393C Method and apparatus for drug delivery using supercritical solutions |
| 05/28/2002 | CA2121256C Secreted mac-2-binding glycoprotein |
| 05/28/2002 | CA2079493C Imaging agent for diagnosis |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040061A2 Immunocompetent animals including xenogeneic implants of mesenchymal stem cells |
| 05/23/2002 | WO2002040060A2 Conjugates of an antioxidants with metal chelating ligands |
| 05/23/2002 | WO2001076637A3 Peptide conjugates for drug delivery |
| 05/23/2002 | US20020062491 Method of producing primary hepatocellular carcinoma-bearing model animals |
| 05/23/2002 | US20020061909 Vitronectin receptor antagonist pharmaceuticals |
| 05/23/2002 | US20020061835 In vivo delivery methods and compositions |
| 05/23/2002 | US20020061291 For screening potential drugs for toxicity toward introduced cells or capacity to stimulate differentiation and/or proliferation; cancer diagnosis |
| 05/23/2002 | US20020061280 For identification of the sentinel lymph node that drains the tissue or organ of interest, such as those affected by neoplasm or disease; contrast agent of specified particle size associates with said lymph structure |
| 05/23/2002 | US20020061278 With a dye that binds to chitin and emits fluorescence upon exposure to light; detecting insects such as lice, ticks or fungi such as Epidermophyton, Microsporum or Trichophyton species |
| 05/23/2002 | CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | CA2421182A1 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications |
| 05/22/2002 | EP1207391A1 Method for screening targeting dds preparation |
| 05/22/2002 | EP1206906A1 Mouse having human cytochrome p450 transferred therein |
| 05/22/2002 | EP1206488A2 Method for isolating and purifying grass pollen allergens |
| 05/22/2002 | EP1206288A2 Targeted fiberless radiative effectors |
| 05/22/2002 | EP1206287A1 Novel high viscosity embolizing compositions |
| 05/22/2002 | EP1206286A1 Administering a gravity segregation dispersion by continuous infusion |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206178A1 A large animal model of invasive pulmonary aspergillosis in an immunocompromised host |
| 05/22/2002 | EP0745085B1 Texaphyrin metal complexes having improved functionalization |
| 05/22/2002 | CN1350546A 结核诊断测验 TB diagnostic test |
| 05/21/2002 | US6391861 Administering hyaluronic acid |
| 05/21/2002 | US6391565 Methods of detecting growth differentiation factor-3 |
| 05/16/2002 | WO2002039112A2 In vivo detection of biomolecule concentrations using fluorescent tags |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038546A1 Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them |
| 05/16/2002 | WO2002038190A2 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates |
| 05/16/2002 | WO2002038173A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 05/16/2002 | WO2002020003A3 Use of carp inhibitors for the treatment of heart diseases |
| 05/16/2002 | WO2002012539A3 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |